throbber
Paper _____
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________
`
`STEADYMED LTD.
`Petitioner
`
`v.
`
`UNITED THERAPEUTICS CORPORATION
`Patent Owner
`
`
`
`U.S. Patent No. 8,497,393
`Issue Date: Jul. 30, 2013
`Title: PROCESS TO PREPARE TREPROSTINIL, THE ACTIVE INGREDIENT IN
`REMODULIN®
`_______________
`
`Case IPR2016-00006
`_______________
`
`
`
`PATENT OWNER’S MOTION TO EXCLUDE
`
`
`
`
`4850-9319-7872.1
`
`

`
`IPR2016-00006
`Patent 8,497,393
`
`
`Patent Owner Docket No. 080618-1601
`
`
`
`INTRODUCTION
`
`I.
`Under 37 C.F.R. § 42.64(c) and the Scheduling Order (Paper 13), United
`
`Therapeutics Corporation (“Patent Owner”) moves to exclude Petitioner’s Exhibit
`
`1022 and the objected-to portions of Exhibits 1009, 1022 and 2059 on the
`
`following grounds:
`
`Exhibit
`
`Description
`
`Reason to Exclude
`
`Ex. 1009
`
`Declaration of Jeffrey D.
`
`Expert not qualified to make these
`
`Winkler, Ph.D. (¶¶3, 31, 46, 48,
`
`conclusory statements
`
`54, 57, 63, 71, and 72)
`
`Ex. 1017
`
`A website printout entitled
`
`Hearsay and not authenticated
`
`“Getting Started in HPLC,’
`
`Section 4D: Precision and
`
`Accuracy”
`
`Ex. 1022
`
`Dr. Robin D. Rogers
`
`Exceeds scope of PO Response
`
`Declaration
`
`and does not rely on facts and data
`
`Ex. 2059
`
`Certain portions of Deposition
`
`Likely to create confusion and
`
`in the record
`
`Transcript of Dr. Robert M.
`
`mislead
`
`Williams, Ph.D
`
`4850-9319-7872.1
`
`2
`
`

`
`IPR2016-00006
`Patent 8,497,393
`
`
`
`
`Patent Owner Docket No. 080618-1601
`
`
`
`Petitioner relied on these exhibits as pointed out below in its Petition (Paper
`
`No. 1) and Petitioner’s Reply (Paper No. 52). Patent Owner also moves to exclude
`
`the portions of Petitioner’s Petition and Reply, which rely on these exhibits.
`
`II.
`
`PATENT OWNER TIMELY OBJECTED
`
`Patent Owner timely objected, on April 22, 2016, to Exhibits 1009 and 1017,
`
`which were submitted with the Petition, which was instituted on April 12, 2016.
`
`See Paper 19. Likewise, Patent Owner timely objected, on October 3, 2016, to
`
`Exhibits 1022 and 2059, which were submitted with the Reply, which was filed on
`
`September 27, 2016. See Paper 55. Petitioner did not supplement or authenticate
`
`any of its evidence in response to these specific objections.
`
`A. Ex. 1009
`
`Specifically, Patent Owner objected to Ex. 1009 in Paper No. 19 for the
`
`following reasons:
`
`Exhibit 1009 is described as “Declaration of Jeffrey D. Winkler, Ph.D.” Patent
`
`Owner objects to Exhibit 1009, under FRE 701, because the opinion testimony
`
`contained in this exhibit reaches legal conclusions for which the declarant has not
`
`established that he is capable of providing, for example, paragraphs 3, 31, 46, 48,
`
`4850-9319-7872.1
`
`3
`
`

`
`IPR2016-00006
`Patent 8,497,393
`
`
`Patent Owner Docket No. 080618-1601
`
`
`
`54, 57, 63, 71, and 72 each recite an unsupported legal conclusion and, thus,
`
`should not be considered by the Board is this proceeding.
`
`B. Ex. 1017
`
`Patent Owner objected to Ex. 1017 in Paper No. 19 for the following reasons:
`
`Exhibit 1017 is described as “‘Getting Started in HPLC,’ Section 4D: Precision
`
`and Accuracy, available at http://www.lcresources.com/resources/getstart/
`
`4d01.htm (accessed Sept. 29, 2015).” Patent Owner objects to Exhibit 1017 under
`
`FRE 901 as not being properly authenticated. Petitioner relies on the exhibit to
`
`prove the truth of the matter asserted therein, but the exhibit fails to meet the
`
`requirements of any hearsay exception or exemption under FRE 803-807.
`
`C. Ex. 1022
`
`Patent Owner objected to Ex. 1022 in Paper No. 55 for the following reasons:
`
`Exhibit 1022 is described as “Dr. Robin D. Rogers Declaration.”
`
`(a) Patent Owner objects to Exhibit 1022 under 37 CFR 42.23 because the
`
`opinion testimony contained in this exhibit contains opinions, including
`
`paragraphs 44-48, that are not responsive to the Patent Owner Response and,
`
`thus, should not be considered by the PTAB in this proceeding. See 37
`
`C.F.R. § 41.41(b);
`
`4850-9319-7872.1
`
`4
`
`

`
`IPR2016-00006
`Patent 8,497,393
`
`
`Patent Owner Docket No. 080618-1601
`
`
`
`(b) Patent Owner objects to Exhibit 1022 under FRE 702-703 as including
`
`opinions, including paragraphs 84-86, that rely on facts and data that are not
`
`in the record as to how a melting point was calculated;
`
`(c) Patent Owner objects to Exhibit 1022 under FRE 702-703 as including
`
`opinions, including paragraph 87, that rely on facts and data that are not in
`
`the record to conclude that a melting point range is narrow.
`
`D. Ex. 2059
`
`Patent Owner objected to Ex. 2059 in Paper No. 55 for the following reasons:
`
`Patent Owner objects to the Reply at pages 2, 3, 4, 7, 8, and 24 for citing
`
`portions of Ex. 2059 (Williams deposition transcript at 112-113 and 217-219)
`
`under FRE 402-403 as being likely to cause confusion pursuant to the objection
`
`made at the deposition at p. 112 of the transcript that the questions
`
`mischaracterized earlier testimony and documents shown to the witness.
`
`Patent Owner objects to the Reply at page 15 for citing portions of Ex. 2059
`
`(Williams deposition transcript at 180) under FRE 402-403 as being likely to cause
`
`confusion pursuant to the objection made at the deposition at p. 181 of the
`
`transcript that the earlier questions misrepresented the document shown to the
`
`witness.
`
`
`
`4850-9319-7872.1
`
`5
`
`

`
`IPR2016-00006
`Patent 8,497,393
`
`
`III. ARGUMENT
`
`Patent Owner Docket No. 080618-1601
`
`
`
`A. The Conclusory Statements of Dr. Winkler (Ex. 1009) Should be
`Excluded
`
`Under FRE 702, a witness may be qualified to testify as an expert if “the
`
`expert’s scientific, technical, or other specialized knowledge will help the trier of
`
`fact to understand the evidence or to determine a fact in issue.” In paragraphs 3,
`
`31 46, 48, 54, 57, 63, 71, and 72 of his declaration (Ex. 1009), Dr. Winkler gives
`
`opinions for which he lacks the requisite expertise.
`
`While Dr. Winkler may be qualified in organic chemistry, Dr. Winkler offers
`
`several opinions that are purely legal conclusions or otherwise unsupported
`
`conclusory statements about subjects that he is not qualified to make. For
`
`example, in each of the paragraphs cited above, Dr. Winker concludes that a prior
`
`art reference either “anticipates,” “inherently” discloses or renders “obvious”
`
`claim limitations. Anticipation, inherency and obviousness are legal concepts that
`
`are beyond Dr. Winker’s expertise. Rather, Dr. Winker’s declaration should be
`
`limited to his opinions that are within the field of organic chemistry. Accordingly,
`
`paragraphs 3, 31, 46, 48, 54, 57, 63, 71, and 72 of Exhibit 1017 should be
`
`excluded. See The Medicines Co. v. Mylan Inc., No. 11-CV-1285, 2014 WL
`
`1758135, at *6 (N.D. Ill. May 2, 2014) (“expert testimony that contains a legal
`
`conclusion that determines the outcome of a case is inadmissible.”).
`
`4850-9319-7872.1
`
`6
`
`

`
`IPR2016-00006
`Patent 8,497,393
`
`
`Patent Owner Docket No. 080618-1601
`
`
`
`These conclusory statements of Dr. Winkler are relied upon in the Petition at
`
`pp. 21, 24, and 25 and in the Petitioner’s Reply at p. 11, which accordingly, should
`
`also be excluded.
`
`B.
`
`Exhibit 1017 Should be Excluded as Inadmissible Hearsay and
`Not Properly Authenticated Evidence
`
`Exhibit 1017 should be excluded because it contains hearsay under FRE 802.
`
`The asserted copyright date and asserted revision date on page 3 of the exhibit are
`
`hearsay (as are the purported web address and the date in the footer of the
`
`document). See Hilgraeve, Inc. v. Symantec Corp., 271 F. Supp. 2d 964, 974 (E.D.
`
`Mich. 2003) (copyright “dates imprinted on . . . documents are hearsay when
`
`offered to prove the truth of the matter asserted”). In his declaration (Ex. 1009),
`
`Dr. Winkler relies on Exhibit 1017 for the proposition that “the literature on
`
`HPLC's precision indicates that the ‘RSD’ or ‘relative standard deviation’ for a
`
`typical instrument is about 1%.” Exhibit 1009 at ¶ 70. It appears that Dr.
`
`Winkler’s statement at ¶ 70 is referencing the text of Ex. 1017 which reads: “[f]or
`
`most purposes, HPLC methods are expected to have CV values on the order of
`
`1%” (see Winkler Deposition Transcript, Ex. 2051 at pp. 97-98). This statement in
`
`Ex. 1017 (relied upon by Dr. Winkler at ¶ 70 of his Declaration) is simply hearsay
`
`for which no exception applies and should be excluded. See FRE 802.
`
`4850-9319-7872.1
`
`7
`
`

`
`IPR2016-00006
`Patent 8,497,393
`
`
`Patent Owner Docket No. 080618-1601
`
`
`
`Exhibit 1017 should also be excluded because it has not been authenticated
`
`pursuant to FRE 901, and it is not a self-authenticating document pursuant to FRE
`
`902. Petitioner offers it as a print-out from a web site (Petition, Paper 1 at ii) but
`
`has made no attempt to authenticate the exhibit following Patent Owner’s
`
`objection. Petitioner provided no testimony from any witness about when, where,
`
`or how this document was obtained. Petitioner could have provided supplemental
`
`evidence directed to authentication, but Petitioner provided no testimony from any
`
`witness that Ex. 1017 is what Petitioner purports it to be. Printouts from web sites
`
`are not self-authenticating. See Veeam Software Corp. v. Symantec Corp.,
`
`IPR2013-00142, Paper 11 at 9 (P.T.A.B. Aug. 7, 2013) (“under the Federal Rules
`
`of Evidence, authentication of [website printouts] is required”). Accordingly,
`
`Exhibit 1017 has not been properly authenticated and should be excluded.
`
`The Winkler Declaration (Ex. 1009) relies upon Ex. 1017 in paragraph 70. In
`
`addition, the Petition relies upon these portions of the Winkler Declaration and Ex.
`
`1017 at pp. 21, 29, 44, 45, and 56, and the Petitioner’s Reply relies upon them at
`
`pp. 12, 13, and 15.
`
`C. Certain Portions of Dr. Rogers’ Declaration (Ex. 1022) Should be
`Excluded
`
`First, paragraphs 44-48 of Dr. Roger’s declaration (Ex. 1022) do not respond to
`
`the Patent Owner Response and should be excluded under 37 C.F.R. § 41.41(b). In
`
`4850-9319-7872.1
`
`8
`
`

`
`IPR2016-00006
`Patent 8,497,393
`
`
`Patent Owner Docket No. 080618-1601
`
`
`
`paragraphs 44-48 of his declaration, Dr. Rogers provides opinions about Form A’s
`
`melting point range and also thermogravimetric analysis. However, these opinions
`
`do not rebut any portion of the Patent Owner Response. Accordingly, such
`
`opinions are new opinions, which are not proper for an expert declaration
`
`submitted with a Petitioner Reply brief, and should be excluded under 37 C.F.R. §
`
`41.41(b).
`
`Second, paragraphs 84-86 rely on facts and data that are not in the record and
`
`are improper under FRE 702-703. Paragraphs 84-87 offer opinions as to how a
`
`melting point is calculated by an unspecified piece of software and also the relative
`
`breadth of a melting point range without any reference being cited against which to
`
`judge the breadth of the range. These paragraphs are not supported by citation to
`
`any reference and merely conclusory statements made by Dr. Rogers.
`
`Accordingly, such opinions should be excluded.
`
`These paragraphs of Dr. Roger’s Declaration are relied upon in Petitioner’s
`
`Reply at p. 15, which accordingly, should also be excluded.
`
`D. The Portions of Dr. Williams’ Testimony That Were
`Mischaracterized Should be Excluded
`
`Petitioner’s Reply to Patent Owner’s Response includes a number of
`
`statements and references that misrepresent certain testimony from the deposition
`
`transcript of Dr. Williams (Ex. 2059). In particular, in these pages of the Reply,
`
`4850-9319-7872.1
`
`9
`
`

`
`IPR2016-00006
`Patent 8,497,393
`
`
`Patent Owner Docket No. 080618-1601
`
`
`
`Petitioner mischaracterizes portions of Dr. Williams’ testimony despite the
`
`objections of Patent Owner’s counsel (Ms. Hasper), who objected that Petitioner’s
`
`counsel (Mr. Pollack) had mischaracterized earlier testimony and various exhibits
`
`(Ex. 2059 at 112:22-113:20, 180:9-25, 217:11-219:20), which renders Dr.
`
`Williams testimony confusing, misleading, and more prejudicial than probative,
`
`and, therefore, inadmissible under FRE 403.
`
`First, Patent Owner objects to the Petitioner’s Reply at pages 2, 3, 4, 7, 8, and
`
`24 for citing portions of Ex. 2059 (Williams deposition transcript at pp. 112-113
`
`and 217-219) under FRE 402-403 as being likely to cause confusion pursuant to
`
`the objection made at the deposition at p. 112 of the Williams deposition transcript
`
`that the questions in those sections mischaracterized his earlier testimony and
`
`documents shown to the witness.
`
`Second, Patent Owner objects to the Petitioner’s Reply at page 15 for citing
`
`portions of Ex. 2059 (Williams deposition transcript at p. 180) under FRE 402-403
`
`as being likely to cause confusion pursuant to the objection made at the deposition
`
`at p. 181 of the transcript that the earlier questions misrepresented the document
`
`shown to the witness.
`
`4850-9319-7872.1
`
`10
`
`

`
`IPR2016-00006
`Patent 8,497,393
`
`
`Patent Owner Docket No. 080618-1601
`
`
`
`These mischaracterized portions of Dr. Williams’ testimony are relied upon in
`
`Petitioner’s Reply at pp. 2, 3, 4, 7, 8, 15, and 24, which accordingly, should also be
`
`excluded.
`
`IV. CONCLUSION
`
`For at least the reasons provided above, Patent Owner urges the Board to grant
`
`this motion and exclude exhibits Exhibit 1017, the objected-to portions of Exhibits
`
`1009, 1022 and 2059, as well as the arguments of Petitioner that rely on these
`
`exhibits in the Petition and in Petitioner’s Reply as set forth above.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`/Stephen B. Maebius/
`Stephen B. Maebius
`Registration No. 35,264
`Counsel for Patent Owner
`
`
`Date: Nov. 1, 2016
`
`
`
`
`
`
`
`4850-9319-7872.1
`
`11
`
`

`
`IPR2016-00006
`Patent 8,497,393
`
`
`Attorney Docket No. 080618-1601
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the foregoing Patent Owner’s Motion to
`
`Exclude was served on counsel of record on Nov. 1, 2016, by filing this document through the
`
`PTAB E2E System as well as delivering a copy via email to the counsel of record for the
`
`Petitioner at the following address: Steadymed-IPR@dlapiper.com.
`
`/Stephen B. Maebius/
`Stephen B. Maebius
`Foley & Lardner LLP
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Date: Nov. 1, 2016
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`4850-9319-7872.1

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket